FDA clears Microbot’s LIBERTY endovascular robot
September 8, 2025
The FDA’s clearance of LIBERTY follows the completion of Microbot’s pivotal trial in April 2025, achieving a 100% success rate in robotic navigation.
The FDA’s clearance of LIBERTY follows the completion of Microbot’s pivotal trial in April 2025, achieving a 100% success rate in robotic navigation.
Researchers at University of Tsukuba have demonstrated for the first time that brain regions responsible for high-level motor planning and preparation, such as the premotor cortex, are activated when a cyborg-type robot is volitionally controlled.
Lifeward (Nasdaq:LFWD) announced today that it received CE mark approval for its ReWalk 7 personal exoskeleton.
Surgerii Robotics announced on LinkedIn today that its Shurui single-port surgical robot garnered CE mark approval in Europe.
Having lived with an ALS diagnosis since 2018, Kate Nycz can tell you firsthand what it’s like to slowly lose motor function for basic tasks. “My arm can get to maybe 90 degrees, but then it fatigues and falls,” the 39-year-old said. “To eat or do a repetitive motion with my right hand, which was my dominant hand, is difficult. I’ve mainly become left-handed.”
Microbot Medical (Nasdaq:MBOT) announced today that it received a new patent covering a modular robotic surgical system.
An international research team led by the University of Waterloo is developing technology to dissolve painful kidney stones in the urinary tract using tiny robots. The research is published in the journal Advanced Healthcare Materials.
Stereotaxis (NYSE:STXS) announced today that it received FDA 510(k) clearance for its Magic Sweep navigation catheter.
Learn how “robot metabolism” allows machines to take material from their surroundings to “grow” and to “heal.”
Sculpteo has announced a collaboration with My Human Kit, a French association specialising in inclusive innovation in the design and manufacture of personalised, accessible, and sustainable prosthetics.